Over 80 percent of 200 COVID-19 sufferers in a hospital in Spain have vitamin D deficiency, relating to new research published when looking at the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Vitamin D is a hormone the kidneys generate that manages blood calcium amount and impacts the immune protection system. Vitamin D deficiency happens to be connected to many health problems, although scientific studies are still underway into why the hormone impacts other systems regarding the body. Many studies point out the beneficial affectation of vitamin D on the immune protection system, especially about protecting infections.

“One approach is always to identify and treat vitamin D deficiency, particularly in high-risk individuals, for instance, the elderly, patients with comorbidities, and nursing home residents, who will be the key target population for the COVID-19,” said study co-author José L. Hernández, Ph.D., regarding the University of Cantabria in Santander, Spain. “Vitamin D treatment should always be recommended in COVID-19 patients with lower levels of vitamin D circulating when you look at the blood because this approach could have beneficial effects both in the musculoskeletal in addition to the immune protection system.”

The investigators found that 80 percent of 216 COVID-19 patients in the Hospital Universitario Marqués de Valdecilla had vitamin D deficiency, and men had lower vitamin D levels than women. COVID-19 patients with reduce vitamin D levels also had increased serum amounts of inflammatory markers such as ferritin and D-dimer.
Reference
Over 80% of Hospitalized COVID-19 Patients Have Vitamin D Deficiency, Study Finds. https://scitechdaily.com/over-80-of-hospitalized-covid-19-patients-have-vitamin-d-deficiency-study-finds/